Lonza has been a dominant player in contract development and manufacturing for decades. We think its outlook is bright, especially as drug manufacturing becomes more complex, with biologics and cell ...

The global Empty Capsules Market, valued at US$3.05 billion in 2024, stood at US$3.19 billion in 2025 and is projected to advance at a resilient CAGR of 5.6% from 2025 to 2030, culminating in a ...

Shares in Swiss firms dropped on Monday morning as markets digested the consequences of US president Donald Trump’s high tariffs. The Swiss Market Index dropped by 1.9 per cent to 11,835 francs upon ...

Review quarterly and annual revenue, net income, and cash flow for Lonza Group Ltd (LONN:XSWX) stock through the last fiscal year.

The subdued stock price reaction suggests that Lonza Group AG's (VTX:LONN) strong earnings didn't offer any surprises. Our analysis suggests that investors might be missing some promising details ...

The subdued stock price reaction suggests that Lonza Group AG's (VTX:LONN) strong earnings didn't offer any surprises. Our analysis suggests that investors might be missing some promising details.

Detailed price information for Lonza Group Ag ADR (LZAGY) from The Globe and Mail including charting and trades.

Lonza Group Revenues Beat Expectations Revenue exceeded analyst estimates by 2.4%. Earnings per share (EPS) was mostly in line with analyst estimates.

Detailed price information for Lonza Group Ag ADR (LZAGY) from The Globe and Mail including charting and trades.